Accelerating Lung Cancer Diagnosis Through Liquid Biopsy

Official Title

Accelerating Lung Cancer Diagnosis Through Liquid Biopsy


This study will assess the utility of liquid biopsy to accelerate the time to treatment for patients with newly diagnosed advanced non-small cell lung cancer, compared to the conventional diagnostic pathway of molecular testing of tumour tissue after imaging and biopsy.

Trial Description

Primary Outcome:

  • Time to treatment
Secondary Outcome:
  • Time to treatment - non-smoker subgroup
  • Turnaround time
  • Concordance between liquid and tissue
  • Costs of upfront use of liquid biopsy vs standard tissue profiling

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society